Vanda Shares Fall Premarket After Company Rejects Takeover Bids
By Colin Kellaher Shares of Vanda Pharmaceuticals moved lower in premarket trading Thursday after the pharmaceutical company said it has rejected a pair of takeover proposals as inadequate. Vanda la
Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Thursday.Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) fell sharply in today's pre-market trading
Express News | Shares of Vanda Pharmaceuticals Down 6% Premarket as Co Rejects Future Pak and Cycle Pharma's Takeover Offers
Reported Wednesday, Vanda Pharmaceuticals Rejects Unsolicited Takeover Bids, Citing Undervaluation
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that the Company's Board of Directors (the "Board"), following careful review and consultation with its independent financial and legal
Express News | Vanda Pharmaceuticals Inc - Proposal From Cycle Group and Revised Proposal From Future Pak Undervalue Vanda
Express News | Vanda Pharmaceuticals Inc - Board Has Rejected Proposals
Express News | Vanda Pharmaceuticals Board of Directors Determines That Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and Its Shareholders
Express News | Butler Hall Capital LLC: Believes Sales Process Could Yield Fair Value of $13.00-$22.00 per Share for Vanda Pharmaceuticals
Express News | Butler Hall Capital LLC: Reiterate Demand Vanda Pharmaceuticals Immediately Form Independent Special Committee to Run Full Sales Process
Express News | Butler Hall Capital LLC: Issued Open Letter to Vanda Pharmaceuticals
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor Drug Pipeline Market 2024 Featuring Vanda Pharmaceuticals, Novartis, Vernalis, Levolta Pharmaceuticals, & Vertex Pharmaceuticals
Sector Update: Health Care Stocks Softer Thursday Afternoon
Health care stocks fell Thursday afternoon with the NYSE Health Care Index down 0.5% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.3%. The iShares Biotechnology ETF (IBB) fell 0.4%. I
Express News | Vanda Pharmaceuticals Shares Extend Gains, Last up 13.4%
Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Dow Jones index falling around 200 points on Thursday.Shares of Tesla Inc (NASDAQ:TSLA) rose sharply during Thursday's session after CEO Elon Musk said the company's s
Express News | Vanda Pharmaceuticals Receives Revised Unsolicited Acquisition Proposal From Future Pak For $8.50-$9.00 Per Share In Cash Plus Contingent Value Rights; No Shareholder Action Required At This Time
Express News | Vanda Pharmaceuticals Inc - Board Will Carefully Review and Evaluate Revised, Non-Binding Proposal
Express News | Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal From Future Pak
Express News | Vanda Pharmaceuticals Shares up 3.2% Premarket After Future Pak Raises Cash Portion of Offer to Buy Co
Express News | Vanda Pharmaceuticals Shares Are Trading Higher After Future Pak Increased the Cash Portion of Its Offer to $8.50-$9.00 per Share
Express News | Future Pak Increases Cash Portion Of Its Offer For Vanda Pharmaceuticals By $0.75-$1.25 To $8.50-$9.00 Per Share
No Data